purple-menu-iconbanner-menu-icon-open

RXL

Ultra Health Care

Investment Objective

ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q3 2022
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund + Index 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
RXL Market Price 2.09% -0.34% -3.74% -17.34% 4.60% 26.19% 20.84% 27.32% 17.43% 01/30/2007
RXL NAV 1.86% -0.37% -3.81% -17.28% 4.70% 26.15% 20.73% 27.43% 17.43% 01/30/2007

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker RXL
  • Intraday Ticker RXL.IV
  • CUSIP 74347R735
  • Inception Date 1/30/07
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.04%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 7/01/2022
  • NAV $89.58
  • NAV Change $+2.31 up caret
  • Market Price $89.31
  • Market Price Change $+2.06 up caret
  • Trading Volume (M) 2,202
  • 30-Day Median Bid Ask Spread 0.15%
  • View Premium / Discount
Snapshot
  • Ticker RXL
  • Intraday Ticker RXL.IV
  • CUSIP 74347R735
  • Inception Date 1/30/07
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.04%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 7/01/2022
  • NAV $89.58
  • NAV Change $+2.31 up caret
  • Market Price $89.31
  • Market Price Change $+2.06 up caret
  • Trading Volume (M) 2,202
  • 30-Day Median Bid Ask Spread 0.15%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/22.

Exposures

Index as of 3/31/2022

Holdings

as of 7/01/2022

Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts
35.35% -- DJ U.S. HEALTH CARE INDEX SWAP UBS AG 36,418,275 -- 26,302
27.32% -- DJ U.S. HEALTH CARE INDEX SWAP CITIBANK NA 28,145,171 -- 20,327
25.99% -- DJ U.S. HEALTH CARE INDEX SWAP GOLDMAN SACHS INTERNATIONAL 26,773,012 -- 19,336
21.28% -- DJ U.S. HEALTH CARE INDEX SWAP BANK OF AMERICA NA 21,915,765 -- 15,828
7.72% UNH UNITEDHEALTH GROUP INC -- $7,956,059.80 15,377
7.52% JNJ JOHNSON & JOHNSON -- $7,741,440.96 43,123
5.32% -- DJ U.S. HEALTH CARE INDEX SWAP SOCIETE GENERALE 5,483,095 -- 3,960
4.67% PFE PFIZER INC -- $4,809,747.57 91,947
4.32% ABBV ABBVIE INC -- $4,454,663.20 28,964
4.07% LLY ELI LILLY & CO -- $4,197,526.17 12,927
3.72% MRK MERCK & CO. INC. -- $3,829,792.38 41,439
3.41% TMO THERMO FISHER SCIENTIFIC INC -- $3,517,700.32 6,416
3.07% ABT ABBOTT LABORATORIES -- $3,163,314.00 28,700
2.66% DHR DANAHER CORP -- $2,736,878.30 10,606
2.60% BMY BRISTOL-MYERS SQUIBB CO -- $2,680,793.92 34,888
2.09% AMGN AMGEN INC -- $2,150,035.80 8,756
1.96% CVS CVS HEALTH CORP -- $2,017,643.32 21,478
1.95% MDT MEDTRONIC PLC -- $2,008,897.92 21,984
1.86% ELV ELEVANCE HEALTH INC -- $1,920,592.96 3,952
1.35% CI CIGNA CORP -- $1,393,756.00 5,200
1.30% ZTS ZOETIS INC -- $1,343,333.31 7,711
1.24% GILD GILEAD SCIENCES INC -- $1,282,059.24 20,559
1.18% ISRG INTUITIVE SURGICAL INC -- $1,212,692.40 5,884
1.17% VRTX VERTEX PHARMACEUTICALS INC -- $1,203,870.80 4,190
1.14% BDX BECTON DICKINSON AND CO -- $1,176,661.40 4,673
1.09% SYK STRYKER CORP -- $1,124,491.76 5,516
1.02% REGN REGENERON PHARMACEUTICALS -- $1,054,453.40 1,771
0.97% HUM HUMANA INC -- $994,799.92 2,077
0.96% EW EDWARDS LIFESCIENCES CORP -- $992,209.32 10,188
0.86% BSX BOSTON SCIENTIFIC CORP -- $890,384.25 23,425
0.83% MRNA MODERNA INC -- $850,516.40 5,672
0.80% CNC CENTENE CORP -- $826,236.64 9,584
0.76% MCK MCKESSON CORP -- $784,940.46 2,382
0.65% IQV IQVIA HOLDINGS INC -- $667,085.10 3,102
0.63% HCA HCA HEALTHCARE INC -- $652,973.80 3,730
0.57% A AGILENT TECHNOLOGIES INC -- $586,393.99 4,919
0.52% BAX BAXTER INTERNATIONAL INC -- $540,488.97 8,253
0.50% RMD RESMED INC -- $517,296.56 2,398
0.49% BIIB BIOGEN INC -- $505,722.63 2,401
0.48% DXCM DEXCOM INC -- $499,471.42 6,434
0.48% IDXX IDEXX LABORATORIES INC -- $493,571.88 1,377
0.48% ILMN ILLUMINA INC -- $491,736.96 2,574
0.48% -- DJ U.S. HEALTH CARE INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 490,155 -- 354
0.42% MTD METTLER-TOLEDO INTERNATIONAL -- $432,208.20 372
0.38% SGEN SEAGEN INC -- $396,422.11 2,201
0.36% WST WEST PHARMACEUTICAL SERVICES -- $373,596.36 1,214
0.36% ZBH ZIMMER BIOMET HOLDINGS INC -- $368,472.45 3,435
0.36% LH LABORATORY CRP OF AMER HLDGS -- $366,228.80 1,520
0.34% STE STERIS PLC -- $346,185.36 1,641
0.32% WAT WATERS CORP -- $332,510.43 987
0.31% AVTR AVANTOR INC -- $316,226.44 10,004
0.31% CTLT CATALENT INC -- $314,317.74 2,937
0.30% HZNP HORIZON THERAPEUTICS PLC -- $304,524.28 3,767
0.29% ALGN ALIGN TECHNOLOGY INC -- $297,055.34 1,201
0.28% ALNY ALNYLAM PHARMACEUTICALS INC -- $293,535.00 1,980
0.28% HOLX HOLOGIC INC -- $286,732.32 4,088
0.26% MOH MOLINA HEALTHCARE INC -- $272,149.80 962
0.26% DGX QUEST DIAGNOSTICS INC -- $262,972.32 1,924
0.25% BMRN BIOMARIN PHARMACEUTICAL INC -- $257,659.36 3,032
0.25% PODD INSULET CORP -- $257,485.02 1,137
0.25% COO COOPER COS INC/THE -- $257,356.08 808
0.25% RPRX ROYALTY PHARMA PLC- CL A -- $253,106.28 5,922
0.23% INCY INCYTE CORP -- $239,689.62 3,086
0.22% TECH BIO-TECHNE CORP -- $227,094.74 643
0.21% VTRS VIATRIS INC -- $212,818.41 19,871
0.19% TFX TELEFLEX INC -- $196,164.21 769
0.18% ABMD ABIOMED INC -- $190,156.32 747
0.18% CRL CHARLES RIVER LABORATORIES -- $182,285.39 833
0.17% BIO BIO-RAD LABORATORIES-A -- $178,330.70 355
0.17% UTHR UNITED THERAPEUTICS CORP -- $176,596.00 742
0.17% HSIC HENRY SCHEIN INC -- $174,499.93 2,263
0.16% JAZZ JAZZ PHARMACEUTICALS PLC -- $162,068.76 1,022
0.16% ELAN ELANCO ANIMAL HEALTH INC -- $160,238.02 7,771
0.15% NBIX NEUROCRINE BIOSCIENCES INC -- $155,524.75 1,567
0.15% BHVN BIOHAVEN PHARMACEUTICAL HOLD -- $150,541.16 1,036
0.14% OGN ORGANON & CO -- $142,377.25 4,157
0.14% RGEN REPLIGEN CORP -- $140,709.40 845
0.12% XRAY DENTSPLY SIRONA INC -- $127,858.40 3,532
0.12% SYNH SYNEOS HEALTH INC -- $120,309.17 1,681
0.12% EXAS EXACT SCIENCES CORP -- $118,577.79 2,883
0.11% CHE CHEMED CORP -- $117,825.40 245
0.11% UHS UNIVERSAL HEALTH SERVICES-B -- $116,672.97 1,101
0.11% SWAV SHOCKWAVE MEDICAL INC -- $116,589.94 587
0.11% MASI MASIMO CORP -- $113,748.30 837
0.11% EXEL EXELIXIS INC -- $113,415.06 5,258
0.11% SRPT SAREPTA THERAPEUTICS INC -- $108,568.14 1,434
0.10% NVCR NOVOCURE LTD -- $108,044.20 1,474
0.10% ACHC ACADIA HEALTHCARE CO INC -- $106,224.72 1,484
0.10% NVST ENVISTA HOLDINGS CORP -- $104,308.10 2,665
0.10% BRKR BRUKER CORP -- $104,142.06 1,639
0.10% HALO HALOZYME THERAPEUTICS INC -- $100,569.28 2,261
0.09% THC TENET HEALTHCARE CORP -- $97,130.00 1,766
0.09% TDOC TELADOC HEALTH INC -- $91,881.54 2,638
0.09% PRGO PERRIGO CO PLC -- $90,449.10 2,205
0.09% IONS IONIS PHARMACEUTICALS INC -- $88,489.50 2,325
0.08% AZTA AZENTA INC -- $87,099.23 1,229
0.08% OMCL OMNICELL INC -- $83,643.25 725
0.08% DVA DAVITA INC -- $82,445.12 992
0.08% ALKS ALKERMES PLC -- $81,789.87 2,679
0.08% HQY HEALTHEQUITY INC -- $79,699.94 1,382
0.08% -- QUIDELORTHO CORP COMMON STOCK USD 0.001 -- $79,533.09 819
0.08% LHCG LHC GROUP INC -- $78,920.45 509
0.07% EHC ENCOMPASS HEALTH CORP -- $76,139.44 1,636
0.07% GMED GLOBUS MEDICAL INC - A -- $75,036.00 1,300
0.07% CRSP CRISPR THERAPEUTICS AG -- $74,442.93 1,167
0.07% NVAX NOVAVAX INC -- $73,152.00 1,280
0.07% GH GUARDANT HEALTH INC -- $72,912.20 1,670
0.07% PEN PENUMBRA INC -- $72,906.00 580
0.07% TXG 10X GENOMICS INC-CLASS A -- $72,117.54 1,539
0.07% RARE ULTRAGENYX PHARMACEUTICAL IN -- $71,859.55 1,147
0.07% PINC PREMIER INC-CLASS A -- $70,068.82 1,934
0.06% MEDP MEDPACE HOLDINGS INC -- $65,973.60 441
0.06% TNDM TANDEM DIABETES CARE INC -- $64,776.88 1,048
0.06% IART INTEGRA LIFESCIENCES HOLDING -- $64,460.00 1,172
0.06% NTLA INTELLIA THERAPEUTICS INC -- $62,327.54 1,154
0.06% ARWR ARROWHEAD PHARMACEUTICALS IN -- $62,318.68 1,733
0.06% AMED AMEDISYS INC -- $59,177.88 534
0.06% MRTX MIRATI THERAPEUTICS INC -- $58,296.42 819
0.05% STAA STAAR SURGICAL CO -- $56,524.77 783
0.05% HAE HAEMONETICS CORP/MASS -- $56,414.16 838
0.05% DOCS DOXIMITY INC-CLASS A -- $55,777.68 1,519
0.05% ICUI ICU MEDICAL INC -- $55,341.09 329
0.05% NTRA NATERA INC -- $54,139.38 1,466
0.05% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $52,537.80 1,787
0.05% BPMC BLUEPRINT MEDICINES CORP -- $48,781.61 977
0.05% -- R1 RCM INC COMMON STOCK USD 0.01 -- $48,355.97 2,201
0.05% DNLI DENALI THERAPEUTICS INC -- $47,828.44 1,531
0.04% ENOV ENOVIS CORP -- $43,176.00 771
0.04% NEOG NEOGEN CORP -- $42,938.10 1,767
0.04% OSH OAK STREET HEALTH INC -- $42,933.34 2,291
0.04% NUVA NUVASIVE INC -- $42,871.78 853
0.03% CVET COVETRUS INC -- $35,736.90 1,714
0.03% TWST TWIST BIOSCIENCE CORP -- $34,187.76 922
0.03% FATE FATE THERAPEUTICS INC -- $33,838.44 1,346
0.03% SHC SOTERA HEALTH CO -- $31,872.30 1,622
0.03% VIR VIR BIOTECHNOLOGY INC -- $31,432.05 1,215
0.03% BEAM BEAM THERAPEUTICS INC -- $30,240.40 760
0.03% ACAD ACADIA PHARMACEUTICALS INC -- $27,762.84 1,932
0.02% EMBC EMBECTA CORP -- $24,697.76 947
0.02% ONEM 1LIFE HEALTHCARE INC -- $23,432.40 2,830
0.02% EBS EMERGENT BIOSOLUTIONS INC -- $23,331.39 733
0.02% AGIO AGIOS PHARMACEUTICALS INC -- $21,024.00 900
0.02% -- ENHABIT INC USD -- $18,601.32 818
0.02% AGL AGILON HEALTH INC -- $18,080.00 800
0.02% BBIO BRIDGEBIO PHARMA INC -- $17,528.64 1,767
0.02% NEO NEOGENOMICS INC -- $17,083.17 2,041
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $16,440.66 3,678
0.01% AMWL AMERICAN WELL CORP-CLASS A -- $14,541.80 3,290
0.01% ALLO ALLOGENE THERAPEUTICS INC -- $14,088.24 1,224
0.01% NKTR NEKTAR THERAPEUTICS -- $11,448.75 3,053
0.01% NVTA INVITAE CORP -- $8,783.32 3,458
0.01% GDRX GOODRX HOLDINGS INC-CLASS A -- $7,102.48 1,153
0.01% SGFY SIGNIFY HEALTH INC -CLASS A -- $6,003.44 404
0.01% ZIMV ZIMVIE INC -- $5,430.96 342
-- BLI BERKELEY LIGHTS INC -- $3,767.40 690
-- -- NET OTHER ASSETS (LIABILITIES) -- $16,323,161.78 16,323,162

Index

as of 3/31/2022

  • Total Number of Companies145
  • Price/Earnings Ratio24.592
  • Price/Book Ratio4.811
  • Dividend Yield ( % )1.44
  • Avg. Index Market Capitalization$39.99 billion
About the Index

The Dow Jones U.S. Health Care Index measures the performance of the health care economic sector of the U.S. equity market. Component companies include health care providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series Research & Insights

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This leveraged ProShares ETF seeks a return that is 2x the return of its underlying benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, holding periods of greater than one day can result in returns that are significantly different than the target return, and ProShares' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their holdings as frequently as daily. Investors should consult the prospectus for further details on the calculation of the returns and the risks associated with investing in this product.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Dow Jones U.S. Health Care IndexSM" is a product of Dow Jones Indexes, the marketing name and a licensed trademark of CME Group Index Services LLC ("CME Indexes"). "Dow Jones,®" "DJ," "Dow Jones Indexes" and "Dow Jones U.S. Health Care Index" are service marks of Dow Jones Trademark Holdings, LLC ("Dow Jones") and have been licensed to CME Indexes and sublicensed to ProShares. ProShares have not been passed on by CME Indexes or Dow Jones as to their legality or suitability. ProShares based on the Dow Jones U.S. Health Care Index are not sponsored, endorsed, sold or promoted by CME Indexes or Dow Jones, and they make no representation regarding the advisability of investing in ProShares. THESE ENTITIES AND THEIR AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares ETFs (ProShares Trust and ProShares Trust II) are distributed by SEI Investments Distribution Co., which is not affiliated with the funds' advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.